CGM Academy: virtual education for kids and teens with type 1 diabetes
Official title: Randomized Control Trial Evaluating the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 1 Diabetes
Run by Children's Hospital Los Angeles · NCT06408207 · Data updated 2026-11-12
This trial tests whether a virtual education program helps children and teens (ages 8–18) with type 1 diabetes using Dexcom CGM reduce glucose swings compared with standard education.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 18 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Children's Hospital Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | September 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | February 6, 2026 |
| Trial ID | NCT06408207 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 8–18 with type 1 diabetes for at least 6 months who can use a Dexcom G6/G7-compatible smartphone, speak English or Spanish, and participate in virtual sessions are ideal candidates.
✕Probably not a fit
Patients with known medical adhesive allergies, those without a compatible smartphone or unable to join virtual visits, or those in the early honeymoon phase of diabetes may not benefit from or be eligible for this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized trial comparing a structured virtual education curriculum (interactive workbook, video links, and four online group sessions with diabetes education specialists) to standard education for youth with type 1 diabetes who use Dexcom G6/G7 continuous glucose monitors. The primary outcome is change in glucose variability measured by CGM data, with questionnaires on diabetes distress, family responsibilities, and hours of diabetes education collected at enrollment, week 4, and 6 months. Eligible participants are 8–18 years old with T1D duration of at least 6 months, English or Spanish speakers, and have a smartphone compatible with Dexcom G6/G7. The study is run through Children's Hospital Los Angeles and delivered virtually to enrolled participants.
Why it matters
Potential benefit: If successful, the program could help youth using CGM reduce glucose variability and improve day-to-day glucose management.
How similar studies have gone: Previous research shows CGM and structured diabetes education can improve glycemic outcomes in youth, but this specific virtual, group-based CGM education curriculum is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7 * T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D * Able to speak, read, and write English or Spanish * Smartphone compatible with Dexcom G6 and G7application * Ability to participate in virtual visits Exclusion Criteria: • Known history of medical adhesive allergies
Where it's running
-
Children's Hospital Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Rebecca Barber, PhD, RN — Children's Hospital Los Angeles
- Study coordinator: Rebecca Barber, PhD, RN
- Email: rbarber@chla.usc.edu
- Phone: (323) 361-1359
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring glucose levels to predict diabetes in at-risk individuals
This study is testing if continuous glucose monitoring can help predict type 1 diabetes in young people who are at risk because they have certain antibodies in their blood.
-
National Diabetes Management Program in China
This study is trying to create a nationwide database to help improve the care and understanding of diabetes in China by collecting health information and samples from patients.
-
Understanding the genetics of autoimmune responses in type 1 diabetes
This study is trying to understand how genes and the environment affect the development of type 1 diabetes by looking at families with a history of the disease and healthy individuals.
-
Understanding extremely early-onset type 1 diabetes in infants
This study looks at infants diagnosed with extremely early-onset type 1 diabetes to see how their immune systems and genes differ from those with typical diabetes, hoping to better understand this rare condition.
-
How people with diabetes find and use health information in Reunion and mainland France
This project will see how well people with type 1, type 2, or gestational diabetes in Reunion and France understand and use health information by having them complete a single health literacy questionnaire.
-
GLP-1 analogue treatment for obesity in young adults with type 1 diabetes
This study is testing if a weight-loss medication can help young adults with type 1 diabetes and obesity improve their health over a year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.